INVESCO ($IVZ) posted quarterly earnings results for Q1 2026 on Tuesday, April 28th. The company reported earnings of $0.57 per share, missing estimates of $0.59 by $0.02. The company also reported revenue of $1,264,300,000, missing estimates of $1,283,588,800 by $-19,288,800.
You can see Quiver Quantitative's $IVZ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INVESCO Insider Trading Activity
INVESCO insiders have traded $IVZ stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IVZ stock by insiders over the last 6 months:
- DOUGLAS J SHARP (Senior Managing Director) sold 160,000 shares for an estimated $3,768,832
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
INVESCO Hedge Fund Activity
We have seen 335 institutional investors add shares of INVESCO stock to their portfolio, and 239 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TRIAN FUND MANAGEMENT, L.P. removed 11,657,511 shares (-79.7%) from their portfolio in Q4 2025, for an estimated $306,242,813
- INVESCO LTD. added 8,770,121 shares (+inf%) to their portfolio in Q4 2025, for an estimated $230,391,078
- PRICE T ROWE ASSOCIATES INC /MD/ added 5,292,867 shares (+368.4%) to their portfolio in Q4 2025, for an estimated $139,043,616
- CITADEL ADVISORS LLC removed 4,119,003 shares (-82.7%) from their portfolio in Q4 2025, for an estimated $108,206,208
- BALYASNY ASSET MANAGEMENT L.P. removed 3,300,789 shares (-99.2%) from their portfolio in Q4 2025, for an estimated $86,711,727
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,970,710 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $78,040,551
- SAMLYN CAPITAL, LLC added 2,268,260 shares (+116.8%) to their portfolio in Q4 2025, for an estimated $59,587,190
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
INVESCO Congressional Stock Trading
Members of Congress have traded $IVZ stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $IVZ stock by members of Congress over the last 6 months:
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
INVESCO Analyst Ratings
Wall Street analysts have issued reports on $IVZ in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 01/21/2026
- Deutsche Bank issued a "Buy" rating on 12/17/2025
To track analyst ratings and price targets for INVESCO, check out Quiver Quantitative's $IVZ forecast page.
INVESCO Price Targets
Multiple analysts have issued price targets for $IVZ recently. We have seen 10 analysts offer price targets for $IVZ in the last 6 months, with a median target of $27.5.
Here are some recent targets:
- Kenneth Worthington from JP Morgan set a target price of $25.0 on 04/24/2026
- Benjamin Budish from Barclays set a target price of $24.0 on 04/17/2026
- Brennan Hawken from BMO Capital set a target price of $28.0 on 04/10/2026
- Glenn Schorr from Evercore ISI Group set a target price of $27.0 on 04/10/2026
- Alexander Blostein from Goldman Sachs set a target price of $27.0 on 04/07/2026
- Michael Cyprys from Morgan Stanley set a target price of $26.0 on 04/01/2026
- Stephen Biggar from Argus Research set a target price of $31.0 on 01/28/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
